Extended Data Table 6 Incidence of Treatment-Emergent Adverse Events by System Organ Class, Preferred Term, and Maximum Severity. Safety Population – SYNB1618

From: Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial

  1. AEs are listed first as all AEs associated with each dose. Then they are relisted by System Organ Class (for example, ‘Gastrointestinal disorders’), and then sublisted by preferred term (for example, ‘Nausea’). For System Organ Class where only a single AE type is reported, only the preferred term is provided.
Back to article page